Related Experiment Video
Updated: Mar 17, 2026

05:25
Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
Published on: May 24, 2024
3.8K
Neonatal McCune-Albright syndrome with survival beyond two years
Melinda Pierce1, Brian Scottoline2
1Division of Endocrinology, Department of Pediatrics, Oregon Health and Science University, Portland, Oregon. piercme@ohsu.edu.
American Journal of Medical Genetics. Part A
|July 14, 2016
Summary
McCune-Albright syndrome (MAS) is a rare genetic disorder. This report details a unique neonatal MAS survivor with non-classical symptoms, highlighting potential survivability with early intervention.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- McCune-Albright syndrome (MAS) is a rare genetic disorder caused by a somatic mutation in the GNAS1 gene.
- This mutation affects the Gs alpha subunit, disrupting G-protein coupled receptor signaling pathways.
- MAS can lead to diverse hormonal and non-hormonal manifestations.
Observation:
- A neonate presented with diabetes and suspected cardiac issues, later diagnosed with ACTH-independent Cushing syndrome.
- The patient exhibited multi-system involvement but lacked the classic MAS triad of café-au-lait spots, fibrous dysplasia, or precocious puberty.
- This case represents the only reported survivor of neonatal MAS.
Findings:
- The patient's presentation of neonatal Cushing syndrome and diabetes, without classic MAS features, underscores the syndrome's variable phenotype.
- Successful medical and surgical management led to the patient's survival.
- This case highlights the importance of recognizing MAS beyond its typical presentation.
Implications:
- Clinicians should consider MAS in neonates presenting with atypical endocrine and non-endocrine symptoms.
- Early diagnosis and comprehensive management can improve outcomes for infants with neonatal MAS.
- This report expands the understanding of MAS survivability in its earliest and most severe form.
